NSETrading Window26 Jun 2026 · 26 Jun 2026, 12:25 pm
Trading Window
Bafna Pharmaceuticals Limited · BAFNAPH
✦ AI Summary
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
BAFNAPH_26062026122439_Intimation_For_Closure_of_Trading_Window.pdf
View document text
BAFNA PHARMACEUTICALS LIMITED
REGD. OFFICE: “BAFNA TOWERS”, NO.299, THAMBU CHETTY STREET, CHENNAI – 600001, TAMIL NADU, INDIA
PHONE: 044-25267517/25270992/42677555, FAX: 91-44-25231264, Email: info@bafnapharma.com, Website: www.bafnapharma.com
CIN: L24294TN1995PLCO30698
Date: June 26, 2026
BSE Limited, National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex,
Mumbai - 400001. Bandra East, Mumbai – 400051.
Scrip Code: 532989 Scrip Code: BAFNAPH
Dear Sir/Madam,
Subject: Closure of Trading Window for the Quarter ended June 30, 2026
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from
time to time, read with Company’s Code of Conduct for Prevention of Insider Trading, the
“Trading Window” for dealing in the Company’s Securities by the Designated Persons of
the Company and their immediate relatives, will remain closed from July 01, 2026 till 48
Hours after the declaration of Un-audited Financial Results for the Quarter ending
June 30, 2026 (Both Days Inclusive).
Accordingly, all the Designated Persons of the Company and their immediate relatives
have been intimated not to trade in the Company’s securities during the aforesaid period
of closure of Trading Window.
Kindly take the above information on record.
Thanking You.
For BAFNA PHARMACEUTICALS LIMITED
Mohanachandran A
Company Secretary & Compliance Officer
Factory: No.147, Madhavaram Redhills High Road, Grantlyon Village, Vadakarai Post, Chennai-600 052, TN, India Phone: 9445149001 Email: factory1@bafnapharma.com